Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens-Reference-Cited by-同舟云学术

Epidermal growth factor receptor/heme oxygenase-1 axis is involved in chemoresistance to cisplatin and pirarubicin in HepG2 cell lines and hepatoblastoma specimens

Published:2019-09-26 Issue:12 Volume:35 Page:1369-1378
ISSN:0179-0358
Container-title:Pediatric Surgery International
language:en
Short-container-title:Pediatr Surg Int

Author:

Kobayashi Takashi,Kubota Masayuki,Kinoshita Yoshiaki,Arai Yuki,Oyama Toshiyuki,Yokota Naoki,Saito Koichi,Matsuda Yasunobu,Osawa Mami

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00383-019-04563-5.pdf

Reference24 articles.

1. Latini G, Gallo F, De Felice C (2004) Birth characteristics and hepatoblastoma risk in young children. Cancer 101(1):210

2. Meyers RL (2007) Tumors of the liver in children. Surg Oncol 16(3):195–203

3. Kremer N, Walther AE, Tiao GM (2014) Management of hepatoblastoma: an update. Curr Opin Pediatr 26(3):362–369

4. Hishiki T, Matsunaga T, Sasaki F, Yano M, Ida K, Horie H, Kondo S, Watanabe K, Oue T, Tajiri T, Kamimatsuse A, Ohnuma N, Hiyama E (2011) Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 27(1):1–8

5. Malogolowkin MH, Katzenstein H, Krailo MD, Chen Z, Bowman L, Reynolds M, Finegold M, Greffe B, Rowland J, Newman K, Womer RB, London WB, Castleberry RP (2006) Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 24(18):2879–2884

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of HO-1 and Its Crosstalk with Oxidative Stress in Cancer Cell Survival;Cells;2021-09-13

2. S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression;Molecular Therapy - Oncolytics;2020-12